Chitosan and the urothelial barrier: Effects on ureteral intraluminal drug penetration and peristalsis

Donald L. Pick, Stanislav Shelkovnikov, Noah Canvasser, Michael K. Louie, Jane Tongson-Ignacio, Elspeth M. McDougall, Ralph V. Clayman

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction: Relaxing the ureter prior to endourologic procedures could ease instrument access. In an ex-vivo model, intraluminal nifedipine has been shown to relax the ureter. Chitosan is the deacetylation product of chitin and can alter bladder urothelium. This study examines the effect of nifedipine on peristalsis before and after pretreating the ureter with chitosan. Methods: Intact 4-cm tubular porcine ureteral segments were placed in a novel organ bath. To induce peristalsis, phenylephrine (10 μM) was added. Chitosan (0.5% [w/v], 30 minutes) or Krebs (control) was then used to treat the urothelium. The rate and amplitude of ureteral peristalsis was then measured. Intraluminal nifedipine (1 μM) was then added to the intraluminal reservoir. Peristaltic rate and amplitude and the time to aperistalsis were measured. Methylene blue was then added after treatment with chitosan or control to measure diffusion. Results: After Krebs pretreatment, intraluminal nifedipine (1 μM) significantly reduced peristaltic frequency (p = 0.0184) but did not stop peristalsis after 60 minutes of exposure in six trials. After chitosan, nifedipine (1 μM) stopped ureteral peristalsis within an average of 12.30 ± 4.72 minutes. Chitosan alone did not cause aperistalsis. Intraluminal methylene blue did not diffuse into the extraluminal bath after saline or chitosan pretreatment. Histological analysis of the ureter before and after pretreatment with chitosan showed no urothelial disruption. Conclusions: By pretreating the intraluminal surface of the ureter with chitosan, nifedipine blocks ureteral peristalsis at low concentrations. Chitosan changes ureteral urothelial permeability without barrier disruption and has no observed effect on ureteral contraction.

Original languageEnglish (US)
Pages (from-to)385-390
Number of pages6
JournalJournal of Endourology
Volume25
Issue number3
DOIs
StatePublished - Mar 1 2011
Externally publishedYes

Fingerprint

Peristalsis
Chitosan
Nifedipine
Ureter
Pharmaceutical Preparations
Urothelium
Methylene Blue
Baths
Chitin
Phenylephrine
Permeability
Urinary Bladder
Swine

ASJC Scopus subject areas

  • Urology
  • Medicine(all)

Cite this

Pick, D. L., Shelkovnikov, S., Canvasser, N., Louie, M. K., Tongson-Ignacio, J., McDougall, E. M., & Clayman, R. V. (2011). Chitosan and the urothelial barrier: Effects on ureteral intraluminal drug penetration and peristalsis. Journal of Endourology, 25(3), 385-390. https://doi.org/10.1089/end.2010.0205

Chitosan and the urothelial barrier : Effects on ureteral intraluminal drug penetration and peristalsis. / Pick, Donald L.; Shelkovnikov, Stanislav; Canvasser, Noah; Louie, Michael K.; Tongson-Ignacio, Jane; McDougall, Elspeth M.; Clayman, Ralph V.

In: Journal of Endourology, Vol. 25, No. 3, 01.03.2011, p. 385-390.

Research output: Contribution to journalArticle

Pick, DL, Shelkovnikov, S, Canvasser, N, Louie, MK, Tongson-Ignacio, J, McDougall, EM & Clayman, RV 2011, 'Chitosan and the urothelial barrier: Effects on ureteral intraluminal drug penetration and peristalsis', Journal of Endourology, vol. 25, no. 3, pp. 385-390. https://doi.org/10.1089/end.2010.0205
Pick, Donald L. ; Shelkovnikov, Stanislav ; Canvasser, Noah ; Louie, Michael K. ; Tongson-Ignacio, Jane ; McDougall, Elspeth M. ; Clayman, Ralph V. / Chitosan and the urothelial barrier : Effects on ureteral intraluminal drug penetration and peristalsis. In: Journal of Endourology. 2011 ; Vol. 25, No. 3. pp. 385-390.
@article{2fd75cffb735494884c8ec26d52b988e,
title = "Chitosan and the urothelial barrier: Effects on ureteral intraluminal drug penetration and peristalsis",
abstract = "Introduction: Relaxing the ureter prior to endourologic procedures could ease instrument access. In an ex-vivo model, intraluminal nifedipine has been shown to relax the ureter. Chitosan is the deacetylation product of chitin and can alter bladder urothelium. This study examines the effect of nifedipine on peristalsis before and after pretreating the ureter with chitosan. Methods: Intact 4-cm tubular porcine ureteral segments were placed in a novel organ bath. To induce peristalsis, phenylephrine (10 μM) was added. Chitosan (0.5{\%} [w/v], 30 minutes) or Krebs (control) was then used to treat the urothelium. The rate and amplitude of ureteral peristalsis was then measured. Intraluminal nifedipine (1 μM) was then added to the intraluminal reservoir. Peristaltic rate and amplitude and the time to aperistalsis were measured. Methylene blue was then added after treatment with chitosan or control to measure diffusion. Results: After Krebs pretreatment, intraluminal nifedipine (1 μM) significantly reduced peristaltic frequency (p = 0.0184) but did not stop peristalsis after 60 minutes of exposure in six trials. After chitosan, nifedipine (1 μM) stopped ureteral peristalsis within an average of 12.30 ± 4.72 minutes. Chitosan alone did not cause aperistalsis. Intraluminal methylene blue did not diffuse into the extraluminal bath after saline or chitosan pretreatment. Histological analysis of the ureter before and after pretreatment with chitosan showed no urothelial disruption. Conclusions: By pretreating the intraluminal surface of the ureter with chitosan, nifedipine blocks ureteral peristalsis at low concentrations. Chitosan changes ureteral urothelial permeability without barrier disruption and has no observed effect on ureteral contraction.",
author = "Pick, {Donald L.} and Stanislav Shelkovnikov and Noah Canvasser and Louie, {Michael K.} and Jane Tongson-Ignacio and McDougall, {Elspeth M.} and Clayman, {Ralph V.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1089/end.2010.0205",
language = "English (US)",
volume = "25",
pages = "385--390",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Chitosan and the urothelial barrier

T2 - Effects on ureteral intraluminal drug penetration and peristalsis

AU - Pick, Donald L.

AU - Shelkovnikov, Stanislav

AU - Canvasser, Noah

AU - Louie, Michael K.

AU - Tongson-Ignacio, Jane

AU - McDougall, Elspeth M.

AU - Clayman, Ralph V.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Introduction: Relaxing the ureter prior to endourologic procedures could ease instrument access. In an ex-vivo model, intraluminal nifedipine has been shown to relax the ureter. Chitosan is the deacetylation product of chitin and can alter bladder urothelium. This study examines the effect of nifedipine on peristalsis before and after pretreating the ureter with chitosan. Methods: Intact 4-cm tubular porcine ureteral segments were placed in a novel organ bath. To induce peristalsis, phenylephrine (10 μM) was added. Chitosan (0.5% [w/v], 30 minutes) or Krebs (control) was then used to treat the urothelium. The rate and amplitude of ureteral peristalsis was then measured. Intraluminal nifedipine (1 μM) was then added to the intraluminal reservoir. Peristaltic rate and amplitude and the time to aperistalsis were measured. Methylene blue was then added after treatment with chitosan or control to measure diffusion. Results: After Krebs pretreatment, intraluminal nifedipine (1 μM) significantly reduced peristaltic frequency (p = 0.0184) but did not stop peristalsis after 60 minutes of exposure in six trials. After chitosan, nifedipine (1 μM) stopped ureteral peristalsis within an average of 12.30 ± 4.72 minutes. Chitosan alone did not cause aperistalsis. Intraluminal methylene blue did not diffuse into the extraluminal bath after saline or chitosan pretreatment. Histological analysis of the ureter before and after pretreatment with chitosan showed no urothelial disruption. Conclusions: By pretreating the intraluminal surface of the ureter with chitosan, nifedipine blocks ureteral peristalsis at low concentrations. Chitosan changes ureteral urothelial permeability without barrier disruption and has no observed effect on ureteral contraction.

AB - Introduction: Relaxing the ureter prior to endourologic procedures could ease instrument access. In an ex-vivo model, intraluminal nifedipine has been shown to relax the ureter. Chitosan is the deacetylation product of chitin and can alter bladder urothelium. This study examines the effect of nifedipine on peristalsis before and after pretreating the ureter with chitosan. Methods: Intact 4-cm tubular porcine ureteral segments were placed in a novel organ bath. To induce peristalsis, phenylephrine (10 μM) was added. Chitosan (0.5% [w/v], 30 minutes) or Krebs (control) was then used to treat the urothelium. The rate and amplitude of ureteral peristalsis was then measured. Intraluminal nifedipine (1 μM) was then added to the intraluminal reservoir. Peristaltic rate and amplitude and the time to aperistalsis were measured. Methylene blue was then added after treatment with chitosan or control to measure diffusion. Results: After Krebs pretreatment, intraluminal nifedipine (1 μM) significantly reduced peristaltic frequency (p = 0.0184) but did not stop peristalsis after 60 minutes of exposure in six trials. After chitosan, nifedipine (1 μM) stopped ureteral peristalsis within an average of 12.30 ± 4.72 minutes. Chitosan alone did not cause aperistalsis. Intraluminal methylene blue did not diffuse into the extraluminal bath after saline or chitosan pretreatment. Histological analysis of the ureter before and after pretreatment with chitosan showed no urothelial disruption. Conclusions: By pretreating the intraluminal surface of the ureter with chitosan, nifedipine blocks ureteral peristalsis at low concentrations. Chitosan changes ureteral urothelial permeability without barrier disruption and has no observed effect on ureteral contraction.

UR - http://www.scopus.com/inward/record.url?scp=79952688974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952688974&partnerID=8YFLogxK

U2 - 10.1089/end.2010.0205

DO - 10.1089/end.2010.0205

M3 - Article

C2 - 21126192

AN - SCOPUS:79952688974

VL - 25

SP - 385

EP - 390

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 3

ER -